Elo Mutual Pension Insurance Co boosted its holdings in Option Care Health, Inc. (NASDAQ:OPCH – Free Report) by 81.5% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 46,549 shares of the company’s stock after buying an additional 20,896 shares during the quarter. Elo Mutual Pension Insurance Co’s holdings in Option Care Health were worth $1,292,000 as of its most recent SEC filing.
Several other institutional investors also recently modified their holdings of OPCH. Cornerstone Planning Group LLC boosted its stake in shares of Option Care Health by 7,621.4% during the 3rd quarter. Cornerstone Planning Group LLC now owns 1,081 shares of the company’s stock worth $30,000 after acquiring an additional 1,067 shares in the last quarter. McIlrath & Eck LLC acquired a new position in shares of Option Care Health in the 2nd quarter valued at $37,000. Elevation Point Wealth Partners LLC acquired a new position in shares of Option Care Health in the 2nd quarter valued at $40,000. EverSource Wealth Advisors LLC increased its stake in Option Care Health by 528.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,407 shares of the company’s stock worth $46,000 after purchasing an additional 1,183 shares in the last quarter. Finally, Hantz Financial Services Inc. raised its holdings in Option Care Health by 987.7% during the 3rd quarter. Hantz Financial Services Inc. now owns 1,414 shares of the company’s stock worth $39,000 after buying an additional 1,284 shares during the period. Institutional investors own 98.05% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of analysts have commented on the stock. Barrington Research upped their price objective on shares of Option Care Health from $38.00 to $42.00 and gave the company an “outperform” rating in a research note on Friday, January 16th. Bank of America raised their price objective on shares of Option Care Health from $32.00 to $35.00 and gave the stock a “buy” rating in a research note on Tuesday, December 9th. Stephens upgraded shares of Option Care Health to a “strong-buy” rating in a research report on Thursday, December 11th. Morgan Stanley boosted their target price on shares of Option Care Health from $35.00 to $38.00 and gave the company an “overweight” rating in a research note on Tuesday, January 13th. Finally, TD Cowen reaffirmed a “hold” rating on shares of Option Care Health in a research report on Tuesday, January 27th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $37.27.
Option Care Health Stock Down 0.8%
Option Care Health stock opened at $30.48 on Friday. The firm has a market cap of $4.77 billion, a PE ratio of 23.81, a P/E/G ratio of 1.72 and a beta of 0.85. The company has a debt-to-equity ratio of 0.87, a quick ratio of 0.96 and a current ratio of 1.53. The firm’s 50 day moving average price is $33.89 and its two-hundred day moving average price is $30.64. Option Care Health, Inc. has a twelve month low of $24.24 and a twelve month high of $36.80.
Option Care Health (NASDAQ:OPCH – Get Free Report) last issued its earnings results on Tuesday, February 24th. The company reported $0.46 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.46. Option Care Health had a net margin of 3.67% and a return on equity of 18.57%. The company had revenue of $1.47 billion during the quarter, compared to analyst estimates of $1.46 billion. During the same quarter last year, the business posted $0.44 EPS. The company’s revenue for the quarter was up 8.8% on a year-over-year basis. On average, research analysts predict that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.
About Option Care Health
Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.
Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.
Further Reading
- Five stocks we like better than Option Care Health
- Silver Is the New Oil—And the World’s Running Dry
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- What happened in Cyprus could be coming here
- Elon Musk’s $1 Quadrillion AI IPO
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH – Free Report).
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.
